Effects of oxymatrine and vincristine on drug resistance in HCT-8/VCR cells and its mechanism

doi:10.12047/j.cjap.5925.2020.075

Abstract

Abstract: Objective: To study the effects of oxymatrine and vincristine on resistance in HCT-8/VCR cells and its mechanism. Methods: HCT-8 / VCR cells were cultured in vitro and were divided into blank control group, oxymatrine group, vincristine group, oxymatrine and vincristine combined group, each group had 6 complexes. The drug resistance of HCT-8/VCR cells was investigated by CCK-8 when treated with vincristine alone or in combination with oxymatrine. The autophagy was determined by monodansylcadaverine (MDC) staining. The level of IL-6 was detected by ELISA. The expressions of autophagy-related gene P62, LC3-Ⅱ / LC3-Ⅰ, Beclin-1 protein and TLR4 were detected by Western blot assay. Results: Oxymatrine combined with vincristine could reduce the drug resistance of HCT-8 / VCR cells by the reversal multiple of 3.23. Compared with the blank control group, the content of autophagosome and the content of IL-6 in the oxymatrine group and the combination group were also decreased significantly (P＜0.01). The content of autophagosome in the vincristine group was increased and the content of IL-6 was also significantly increased (P＜0.01). Compared with the oxymatrine group, the combination group had higher autophagosome content, while IL-6 content was decreased (P＜0.01); Western blot experiments showed that compared with the blank control group, the expression of P62 in the oxymatrine group was decreased (P＜0.05), while the expressions of LC3-Ⅱ / LC3-Ⅰ, Beclin-1 and TLR4 were all increased (P＜0.05). The expression of P62 in the vincristine group and the combined group was increased (P＜0.05), and the expressions of LC3-Ⅱ / LC3-Ⅰ, Beclin-1, and TLR4 were all decreased (P＜0.05). Compared with the vincristine group, the expression of P62 was increased in the combination group (P＜0.05), and the expressions of LC3-Ⅱ / LC3-Ⅰ, Beclin-1, and TLR4 were all decreased (P＜0.05). Conclusion: Oxymatrine combined with vincristine can reduce the drug resistance of HCT-8/VCR cells, which may be related to the regulation of autophagy activity and TLR4 signal activation.

Key words: oxymatrine, HCT-8/VCR cells, autophagy, TLR4, colorectal cancer, vincristine, reversal

CLC Number:

R735.3

SU Jian-wei, ZHOU Xi-han, YE Ying-xia, JIANG Qi. Effects of oxymatrine and vincristine on drug resistance in HCT-8/VCR cells and its mechanism[J]. CJAP, 2020, 36(4): 350-353.

References

[1] 李长龙, 刘建文, 萨晓婴, 等. 长春新碱耐药结肠癌细胞株HCT-8/VCR的建立及其耐药机制的初步研究[J]. 肿瘤, 2009, 29(1): 31-34.
[2] 李秀娟, 李玉珍, 金春亭, 等. 姜黄素作用PTEN/PI3K/AKT通路诱导食管癌EC109细胞凋亡[J]. 中国应用生理学杂志, 2015, 31(2): 174-177.
[3] 王凤杰, 宗星煜, 杜俊龙, 等. 二氢杨梅素对人胃癌MKN45细胞迁移和侵袭的影响及其机制[J]. 中国应用生理学杂志, 2019, 35(5): 428-432.
[4] 王淑静, 刘欢, 赵健凯, 等. 氧化苦参碱对人肝癌HepG2细胞增殖及能量代谢的影响[J]. 中成药, 2017, 39(9): 1932-1935.
[5] 彭向前, 张文会, 李军. 氧化苦参碱逆转多药耐药细胞系K562/A02耐药性的研究[J]. 中国肿瘤临床, 2008(19): 1127-1130.
[6] 冯云, 亢君君, 方宗平, 等. AZD4547促进自噬并促进索拉非尼耐药肝癌细胞的死亡[J]. 细胞与分子免疫学杂志, 2019, 35(4): 339-343.
[7] Shi D, Zhang JJ, Qiu L, et al. Matrine inhibits infiltration of the inflammatory Gr1~(hi) monocyte subset in injured mouse liver through inhibition of monocyte chemoattractant protein-1[J]. Evid Based Complement Alternat Med, 2013, 2013: 580673-580684.
[8] Robinson E, Leung E, Matuszek AM, et al. Virtual screening for novel Atg5-Atg16 complex inhibitors for autophagy modulation[J]. Med Chem Comm, 2015, 6(1): 239-246.
[9] Liu SL, Li XM.Autophagy inhibition enhances sensitivity of endometrial carcinoma cells to paclitaxel[J]. Int J Oncol, 2015, 56(6): 2399-2408.
[10] 陆帅. CD24分子通过自噬途径调控肝细胞肝癌索拉菲尼耐药的机制研究[D]. 南京医科大学, 2018.
[11] 王冰蓉, 孙阳. 耐药卵巢癌的治疗与细胞自噬的相关研究进展[J]. 现代妇产科进展, 2018, 27(1): 72-74.
[12] Cen X, Liu S, Cheng K. The role of Toll-like receptor in inflammation and tumor immunity[J]. Front Pharmacol. 2018, 9: 878.
[13] 吴健. IL-6诱导卵巢癌细胞化疗耐药的作用及作用机制研究[D]. 河北医科大学, 2010.
[14] 韩睿. Metformin抑制IL-6/STAT3信号途径克服肺癌EGFR-TKI获得性耐药的作用和机制的研究[D]. 第三军医大学, 2014.
[15] 林昂. 阻断TLR4信号通路治疗肝癌的研究[D]. 山东大学, 2014.
[16] 张欣. shRNA敲减TLR4对乳腺癌细胞紫杉醇敏感性的影响[D]. 福建医科大学, 2017.